Steatotic liver disease is the overarching term for conditions characterised by abnormal lipid
accumulation in the liver (liver or hepatic steatosis). Steatotic liver disease encompasses …

Noninvasive tests (NITs) are used in all aspects of liver disease management. Their most
prominent break-through since the millennium has been in advancing early detection of liver …

Background Alcohol is the leading cause of liver-related mortality worldwide. The gut–liver
axis is considered a key driver in alcohol-related liver disease. Rifaximin-α improves gut …

For many years non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease
(ALD) have been considered as two biologically and clinically distinct conditions. According …

Distinct structural and dynamic components of portal hyperte... : Hepatology Distinct structural
and dynamic components of portal hypertension in different animal models and human liver …

Abstract Background & Aims Experimental evidence indicates that systemic inflammation
(SI) promotes liver fibrogenesis. This study investigated the potential link between SI and …

Abstract Background & Aims Binge drinking is associated with an increased risk of liver
disease. Morbidity and mortality of alcohol‐related liver disease (ALD) is associated with …

Alcohol consumption is a global phenomenon and a major contributor to alcohol-associated
liver disease (ALD). Detecting individuals at risk of ALD has been challenging, with only a …

Alcohol-related liver disease (ALD) is the primary cause of liver-related mortality and
morbidity. Liver fibrosis remains the best validated surrogate marker for patient prognosis …

Chronic liver disease is a major cause of mortality, with approximately 2 million deaths
worldwide each year, and it poses a significant economic burden. The most common cause …